The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
Open accessAbstract
Multiple sclerosis is characterized morphologically by the key features demyelination, inflammation, gliosis and axonal damage. In recent years, it has become more evident that axonal damage is the major morphological substrate of permanent clinical disability. In our study, we investigated the occurrence of acute axonal damage determined by immunocytochemistry for amyloid precursor protein (APP) which is produced in neurones and accumulates at sites of recent axon transection or damage. The numbers of APP-positive axons in multiple sclerosis lesions were correlated with the disease duration and course. Most APP-positive axons were detected within the first year after disease onset, but acute axonal damage was also detected to a minor degree in lesions of patients with a disease duration of 10 years and more. This effect was not due to the lack of active demyelinating lesions in the chronic disease stage. Late remyelinated lesions (so-called shadow plaques) did not show signs of axon destruction. The number of inflammatory cells showed a decrease over time similar to that of the number of APP-positive axons. There was a significant correlation between the extent of axon damage and the numbers of CD8-positive cytotoxic T cells and macrophages/microglia. Our results indicate that a putative axon-protective treatment should start as early as possible and include strategies preventing T cell/macrophage-mediated axon destruction and leading to remyelination of axons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Jacobs, L. D., Beck, R. W., Simon, J. H., Kinkel, R. P., Brownscheidle, C. M., Murray, T. J., Simonian, N. A., Slasor, P. J., & Sandrock, A. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431301 · Cited by 1,501
Comi, G., Filippi, M., Barkhof, F., Durelli, L., Edan, G., Fernández, O., Hartung, H.-P., Seeldrayers, P., Sørensen, P. S., Rovaris, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04725-5 · Cited by 1,053
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Self-citationBirken, D. L., & Oldendorf, W. H. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80048-x · Cited by 779
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.x5001-0 · Cited by 769
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
Simmons, M. L., Frondoza, C. G., & Coyle, J. T. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90101-s · Cited by 626
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S., Möurk, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.1.49 · Cited by 534
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 519
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
De Stefano, N., Narayanan, S., Francis, G. S., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., Matthews, P. M., & Arnold, D. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.65 · Cited by 505
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
Fu, L. (1998) · Brain · doi:10.1093/brain/121.1.103 · Cited by 481
Evangelou, N. (2000) · Brain · doi:10.1093/brain/123.9.1845 · Cited by 416
Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I., & Miller, D. H. (1995) · Brain · doi:10.1093/brain/118.6.1583 · Cited by 377
Allen, I. V., & McKeown, S. R. (1979) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(79)90142-4 · Cited by 359
Axonal changes in chronic demyelinated cervical spinal cord plaques
Lovas, G., Szilagyi, N., Majtenyi, K., Palkovits, M., & Komoly, S. (2000) · Brain · doi:10.1093/brain/123.2.308 · Cited by 356
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
Thompson, A. J., Montalbán, X., Barkhof, F., Brochet, B., Filippi, M., Miller, D. H., Polman, C. H., Stevenson, V. L., & McDonald, W. I. (2000) · PubMed · Cited by 352
Correlation of magnetization transfer ration with clinical disability in multiple sclerosis
Gass, A., Barker, G. J., Kidd, D., Thorpe, J. W., MacManus, D., Brennan, A., Tofts, P. S., Thompson, A. J., McDonald, W. I., & Miller, D. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360113 · Cited by 343
THE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Redford, E. (1997) · Brain · doi:10.1093/brain/120.12.2149 · Cited by 326
Electrically active axons degenerate when exposed to nitric oxide
Smith, K. J., Kapoor, R., Hall, S. M., & Davies, M. (2001) · Annals of Neurology · doi:10.1002/ana.96 · Cited by 320
Chemical pathology of acute demyelinating lesions and its correlation with disability
De Stefano, N., Matthews, P. M., Antel, J. P., Preul, M., Francis, G., & Arnold, D. L. (1995) · Annals of Neurology · doi:10.1002/ana.410380610 · Cited by 304
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Axonal loss in normal-appearing white matter in a patient with acute MS
Bjartmar, C., Kinkel, R. P., Kidd, G., Rudick, R. A., & Trapp, B. D. (2001) · Neurology · doi:10.1212/wnl.57.7.1248 · Cited by 281
Pierce, J., Trojanowski, J., Graham, D., Smith, D., & McIntosh, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01083.1996 · Cited by 239 · cited 2×
“It persists in transected axons for a period of <30 days (Li et al., 1995; Pierce et al., 1996; Bramlett et al., 1997; Yam et al., 1997) In histopathological studies, a signi®cant reduction of axon density was found in multiple sclerosis lesions (Lovas et al.”
BackgroundComparison of MS clinical phenotypes using conventional and magnetization transfer MRI
Filippi, M., Iannucci, G., Tortorella, C., Minicucci, L., Horsfield, M. A., Colombo, B., Sormani, M. P., & Comi, G. (1999) · Neurology · doi:10.1212/wnl.52.3.588 · Cited by 230
Davie, C. A., Barker, G. J., Thompson, A. J., Tofts, P. S., McDonald, W. I., & Miller, D. H. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.6.736 · Cited by 227
BRAMLETT, H. M., KRAYDIEH, S., GREEN, E. J., & DIETRICH, W. D. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00007 · Cited by 225
Fisher, E., Rudick, R. A., Cutter, G., Baier, M., Miller, D., Weinstock-Guttman, B., Mass, M. K., Dougherty, D. S., & Simonian, N. A. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600602 · Cited by 185
Matthews, P., De Stefano, N., Narayanan, S., Francis, G., Wolinsky, J., Antel, J., & Arnold, D. (1998) · Seminars in Neurology · doi:10.1055/s-2008-1040884 · Cited by 178
Matthews, P. M., Pioro, E., Narayanan, S., Stefano, N. D., Fu, L., Francis, G., Antel, J., Wolfson, C., & Arnold, D. L. (1996) · Brain · doi:10.1093/brain/119.3.715 · Cited by 165
Pelletier, J., Suchet, L., Witjas, T., Habib, M., Guttmann, C. R. G., Salamon, G., Lyon‐Caen, O., & Chérif, A. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.105 · Cited by 160
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions
Mews, I., Bergmann, M., Bunkowski, S., Gullotta, F., & Brück, W. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400203 · Cited by 160
van Walderveen, M. A. A., Nijeholt, G. J. L. À., Adèr, H. J., Jongen, P. J., Polman, C. H., Castelijns, J. A., & Barkhof, F. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.76 · Cited by 154
Sadatipour, B. T., Greer, J. M., & Pender, M. P. (1998) · Annals of Neurology · doi:10.1002/ana.410440621 · Cited by 140
Paolillo, A., Pozzilli, C., Gasperini, C., Giugni, E., Mainero, C., Giuliani, S., Tomassini, V., Millefiorini, E., & Bastianello, S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00259-8 · Cited by 134
Koeberle, P. D., & Ball, A. K. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7113 · Cited by 115
Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion
Yam, P. S., Takasago, T., Dewar, D., Graham, D. I., & McCulloch, J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00290-4 · Cited by 96
Gimsa, U., Peter, S., Lehmann, K. R., Bechmann, I., & Nitsch, R. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00268.x · Cited by 95
Axonal degeneration in the pathogenesis of multiple sclerosis
Silber, E., & Sharief, M. K. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00178-1 · Cited by 93
Schiepers, C. W., Hecke, P. V., Vandenberghe, R. R., Oostende, S. V., Dupont, P. J., Demaerel, P., Bormans, G. M., & Carton, H. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300102 · Cited by 92
Filippi, M., Tortorella, C., & Bozzali, M. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500414 · Cited by 78
Li, G. L., FAROOQUE, M., Holtz, A., & Olsson, Y. (1995) · Journal of Neurotrauma · doi:10.1089/neu.1995.12.269 · Cited by 71
Davie, C. A., Silver, N., Barker, G. J., Tofts, P. S., Thompson, A. J., McDonald, W. I., & Miller, D. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.710 · Cited by 62
Grimaud, J., Barker, G. J., Wang, L., Lai, M., MacManus, D. G., Webb, S. L., Thompson, A. J., McDonald, W. I., Tofts, P. S., & Miller, D. (1999) · Journal of Neurology · doi:10.1007/s004150050491 · Cited by 46
Rawes, J., Calabrese, V. P., Khan, O. A., & DeVries, G. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300601 · Cited by 46
Bitsch, A., da Costa, C., Bunkowski, S., Weber, F., Rieckmann, P., & Brück, W. (1998) · Acta Neuropathologica · doi:10.1007/s004010050813 · Cited by 32
Pesini, P., Kopp, J., Wong, H. C., Walsh, J. H., Grant, G., & Hökfelt, T. G. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01283-4 · Cited by 25
THE PATHOLOGY OF MULTIPLE SCLEROSIS
SPILLER (1897) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-189705000-00042 · Cited by 21
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Demyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Kappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237641.33768.8d · Cited by 681
Metadata
- Authors
- Kuhlmann, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-10-01
- Volume
- 125
- Issue
- 10
- Pages
- 2202-2212
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2119260372
- Cited by
- 775
- References
- 58
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.